nombre del producto: Dehydronandrolone Acetate
Sinónimos: Dehydronandrolone Acetate;Dehydronandrolone-6 Acetate
CAS: 2590-41-2
FM: C20H26O3
megavatios: 314.42
parlamentario: 95-98ºC
Temperatura de almacenamiento: Controlled Substance, -20°C Freezer
Apariencia: polvo blanco
Dehydronandrolone acetate is a key intermediate for the synthesis of fulvestrant (faslodex) and tibolone, while the former was an anti-breast-cancer drug developed by AstraZeneca Company and the latter was a synthetic steroid marketed by Organon Company for post climacteric complains. It is an effective compound that produces quality, long-lasting muscle gains. This is because of the relatively long half-life of the drug. Users report mild side effects, with the biggest side effect being water retention.
Dehydronandrolon acetate(CAS: 2590-41-2) is an effective compound that produces quality, long-lasting muscle gains. This is because of the relatively long half-life of the drug. Users report mild side effects, with the biggest side effect being water retention.
Dehydronandrolon acetate is an effective compound that produces quality, long-lasting muscle gains,with the biggest side effect being water retention.
| Elementos de análisis |
Especificación |
Resultados |
| Descripción |
White to light yellow crystalline powder |
polvo cristalino blanco |
| Punto de fusion |
≥100℃ |
107℃ |
| Specific optical rotation |
-20°～-26° |
-22.5° |
| Pérdida por secado |
≤0.5% |
0.15% |
| Identificación |
Test preparation has maximum
absorption at 282±2nm by
ultraviolet – visible spectrophotometry. |
Calificado |
| Maximum single impurity |
≤1,0% |
0.3% |
| Total impurities |
≤5.0% |
0.8% |
| Ensayo |
≥95.0% |
99.45% |
| Conclusión |
Calificado |
